D
Daniel C. Chung
Researcher at Harvard University
Publications - 307
Citations - 27050
Daniel C. Chung is an academic researcher from Harvard University. The author has contributed to research in topics: Colorectal cancer & Cancer. The author has an hindex of 69, co-authored 290 publications receiving 24211 citations. Previous affiliations of Daniel C. Chung include University of Pennsylvania & Google.
Papers
More filters
Journal ArticleDOI
The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications.
Daniel C. Chung,Anil K. Rustgi +1 more
TL;DR: The key features of normal DNA replication and the mechanisms that ensure the fidelity of this process are highlighted, and the genes involved in DNA mismatch repair are illustrated.
Journal ArticleDOI
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
Joshua M. Francis,Joshua M. Francis,Adam Kiezun,Alex H. Ramos,Alex H. Ramos,Stefano Serra,Chandra Sekhar Pedamallu,Chandra Sekhar Pedamallu,Zhi Rong Qian,Michaela S. Banck,Rahul Kanwar,Amit A. Kulkarni,Anna Karpathakis,Anna Karpathakis,Veronica E. Manzo,Tanupriya Contractor,Juliet Philips,Elizabeth Nickerson,Nam Pho,Susanne M. Hooshmand,Lauren K. Brais,Michael S. Lawrence,Trevor J. Pugh,Aaron McKenna,Andrey Sivachenko,Kristian Cibulskis,Scott L. Carter,Akinyemi I. Ojesina,Akinyemi I. Ojesina,Samuel S. Freeman,Robert T. Jones,Douglas Voet,Gordon Saksena,Daniel Auclair,Robert C. Onofrio,Erica Shefler,Carrie Sougnez,Jonna Grimsby,Lisa Green,Niall J. Lennon,Tim Meyer,Tim Meyer,Martyn Caplin,Daniel C. Chung,Andreas S. Beutler,Shuji Ogino,Christina Thirlwell,Christina Thirlwell,Ramesh A. Shivdasani,Sylvia L. Asa,Sylvia L. Asa,Chris R. Harris,Gad Getz,Matthew H. Kulke,Matthew Meyerson,Matthew Meyerson +55 more
TL;DR: Recurrent somatic mutations and deletions in CDKN1B, the cyclin-dependent kinase inhibitor gene, which encodes p27 are identified, nominating p27 as a tumor suppressor and implicating cell cycle dysregulation in the etiology of SI-NETs.
Journal ArticleDOI
HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.
Yoshifumi Baba,Katsuhiko Nosho,Kaori Shima,Natsumi Irahara,Andrew T. Chan,Jeffrey A. Meyerhardt,Daniel C. Chung,Edward Giovannucci,Edward Giovannucci,Charles S. Fuchs,Charles S. Fuchs,Shuji Ogino,Shuji Ogino +12 more
TL;DR: Hif1A expression is independently associated with poor prognosis in colorectal cancer, suggesting HIF1A as a biomarker with potentially important therapeutic implications, and EPAS1 expression was not significantly associated with patient survival.
Journal ArticleDOI
Reversal of Blindness in Animal Models of Leber Congenital Amaurosis Using Optimized AAV2-mediated Gene Transfer
Jeannette L. Bennicelli,J F Wright,J F Wright,András M. Komáromy,Jonathan B. Jacobs,Bernd Hauck,Olga Zelenaia,Federico Mingozzi,Daniel Hui,Daniel C. Chung,Tonia S. Rex,Zhangyong Wei,Guang Qu,Shangzhen Zhou,Caroline J. Zeiss,Valder R. Arruda,Gregory M. Acland,L. F. Dell'Osso,Katherine A. High,Albert M. Maguire,Jean Bennett +20 more
TL;DR: The data demonstrate that AAV2.RPE65 delivers the RPE65 transgene efficiently and quickly to the appropriate target cells in vivo in animal models, and holds great promise for treatment of LCA due to R PE65 mutations.
Journal ArticleDOI
Priorities for Improving the Management of Gastroenteropancreatic Neuroendocrine Tumors
TL;DR: The most pressing needs were public and physician education, identification of molecular markers for early diagnosis and therapeutic monitoring, improved imaging modalities and molecular prognostication, development of a standardized pathological classification system, and creation of regional centers of expertise with tumor and laboratory data banks.